Piramal Pharma consolidated net profit rises 350.00% in the September 2024 quarter
Net profit of Piramal Pharma rose 350.00% to Rs 22.59 crore in the quarter ended September 2024 as against Rs 5.02 crore during the previous quarter ended September 2023. Sales rose 17.28% to Rs 2241.75 crore in the quarter ended September 2024 as against Rs 1911.38 crore during the previous quarter ended September 2023.
Particulars | Quarter Ended | ||
Sep. 2024 | Sep. 2023 | % Var. | |
Sales | 2241.75 | 1911.38 | 17 |
OPM % | 15.24 | 13.90 | - |
PBDT | 312.34 | 224.07 | 39 |
PBT | 120.12 | 39.56 | 204 |
NP | 22.59 | 5.02 | 350 |
Top Small Finance Bank Stocks in India
9 mins read . Oct 30, 2024
How to do Valuation Analysis of a Company
10 mins read . Oct 30, 2024
Long Unwinding Meaning
12 mins read . Oct 28, 2024